Assessment of mitochondrial dysfunction and monoamine oxidase contribution to oxidative stress in human diabetic hearts

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Duicu, O M ^a   Lighezan, R ^a   Sturza, A ^a   Balica, R ^a   Vaduva, A ^a   Feier, H ^a   Gaspar, M ^a   Ionac, A ^a   Noveanu, L ^a   Borza, C ^a   Muntean, D M ^a   Mornos, C ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; OXIDATIVE STRESS;

CARDIOVASCULAR DYSFUNCTION; CORONARY HEART DISEASE; DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL RESPIRATION; MONOAMINE OXIDASE; SUBSTRATE INDEPENDENTS;

MITOCHONDRIA;

AMINE OXIDASE (FLAVIN CONTAINING); HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); MONOAMINE OXIDASE A, HUMAN; MONOAMINE OXIDASE INHIBITOR;

ADULT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE EXPRESSION; HEART ATRIUM APPENDAGE; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RESPIROMETRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; AGED; CARDIAC MUSCLE; CASE CONTROL STUDY; CELL RESPIRATION; CORONARY DISEASE; DIABETIC CARDIOMYOPATHIES; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEART MITOCHONDRION; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY;

AGED; CASE-CONTROL STUDIES; CELL RESPIRATION; CORONARY DISEASE; DIABETIC CARDIOMYOPATHIES; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOCHONDRIA, HEART; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MYOCARDIUM; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; SPECTROMETRY, FLUORESCENCE;

EID: 84966447565     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/8470394     Document Type: Article

References (48)

1. L. Rydén, P. J. Grant, S. D. Anker et al., "ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD), " European Heart Journal, vol. 34, no. 39, pp. 3035-3087, 2013.
2. Y.-R. Chen and J. L. Zweier, "Cardiac mitochondria and reactive oxygen species generation, " Circulation Research, vol. 114, no. 3, pp. 524-537, 2014.
3. T. Ide, H. Tsutsui, S. Kinugawa et al., "Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium, " Circulation Research, vol. 85, no. 4, pp. 357-363, 1999.
4. T. Ide, H. Tsutsui, S. Kinugawa et al., "Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium, " Circulation Research, vol. 86, no. 2, pp. 152-157, 2000.
5. O. M. Duicu, R. Lighezan, A. Sturza et al., "Monoamineoxidases as potential contributors to oxidative stress in diabetes: time for a study in patients undergoing heart surgery, " BioMed Research International, vol. 2015, Article ID 515437, 9 pages, 2015.
6. M. G. Rosca and C. L. Hoppel, "Mitochondrial dysfunction in heart failure, " Heart Failure Reviews, vol. 18, no. 5, pp. 607-622, 2013.
7. H. Lemieux, S. Semsroth, H. Antretter, D. Höfer, and E. Gnaiger, "Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart, " International Journal of Biochemistry and Cell Biology, vol. 43, no. 12, pp. 1729-1738, 2011.
8. A. M. Cordero-Reyes, A. A. Gupte, K. A. Youker et al., "Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function, " Journal of Molecular and Cellular Cardiology, vol. 68, pp. 98-105, 2014.
9. J. Szendroedi, E. Phielix, and M. Roden, "The role of mitochondria in insulin resistance and type 2 diabetes mellitus, " Nature Reviews Endocrinology, vol. 8, no. 2, pp. 92-103, 2012.
10. S. Boudina, S. Sena, H. Theobald et al., "Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, " Diabetes, vol. 56, no. 10, pp. 2457-2466, 2007.
11. R. Blake and I. A. Trounce, "Mitochondrial dysfunction and complications associated with diabetes, " Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 4, pp. 1404-1412, 2014.
12. D. Montaigne, X. Marechal, A. Coisne et al., "Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients, " Circulation, vol. 130, no. 7, pp. 554-564, 2014.
13. E. J. Anderson, E. Rodriguez, C. A. Anderson, K. Thayne, W. R. Chitwood, and A. P. Kypson, "Increased propensity for cell death in diabetic human heart is mediated by mitochondrialdependent pathways, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 1, pp. H118-H124, 2011.
14. E. J. Anderson, A. P. Kypson, E. Rodriguez, C. A. Anderson, E. J. Lehr, and P. D. Neufer, "Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart, " Journal of the American College of Cardiology, vol. 54, no. 20, pp. 1891-1898, 2009.
15. O. Lorenzo, E. Raḿirez, B. Picatoste, J. Egido, and J. Tuñón, "Alteration of energy substrates and ROS production in diabetic cardiomyopathy, " Mediators of Inflammation, vol. 2013, Article ID 461967, 11 pages, 2013.
16. H. Sies, "Role of metabolic H2O2 generation: redox signaling and oxidative stress, " Journal of Biological Chemistry, vol. 289, no. 13, pp. 8735-8741, 2014.
17. N. Kaludercic, J. Mialet-Perez, N. Paolocci, A. Parini, and F. Di Lisa, "Monoamine oxidases as sources of oxidants in the heart, " Journal ofMolecular and Cellular Cardiology, vol. 73, pp. 34-42, 2014.
18. J. C. Shih, K. Chen, and M. J. Ridd, "Monoamine oxidase: from genes to behavior, " Annual Review of Neuroscience, vol. 22, pp. 197-217, 1999.
19. D. E. Edmondson, "Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications, " Current Pharmaceutical Design, vol. 20, no. 2, pp. 155-160, 2014.
20. P. Bianchi, D. R. Pimentel, M. P. Murphy, W. S. Colucci, and A. Parini, "A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation, " The FASEB Journal, vol. 19, no. 6, pp. 641-643, 2005.
21. P. Bianchi, O. Kunduzova, E. Masini et al., "Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury, " Circulation, vol. 112, no. 21, pp. 3297-3305, 2005.
22. N. Kaludercic, E. Takimoto, T. Nagayama et al., "Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload, " Circulation Research, vol. 106, no. 1, pp. 193-202, 2010.
23. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard et al., "p53-PGC-1 pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice, " Antioxidants & Redox Signaling, vol. 18, no. 1, pp. 5-18, 2013.
24. A. Carpi, R. Menabó, N. Kaludercic, P. Pelicci, F. Di Lisa, and M. Giorgio, "The cardioprotective effects elicited by p66Shc ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury, " Biochimica et Biophysica Acta (BBA)-Bioenergetics, vol. 1787, no. 7, pp. 774-780, 2009.
25. A. Sturza, M. S. Leisegang, A. Babelova et al., "Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta, " Hypertension, vol. 62, no. 1, pp. 140-146, 2013.
26. A. Sturza, O. M. Duicu, A. Vaduva et al., "Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes, " Canadian Journal of Physiology and Pharmacology, vol. 93, no. 7, pp. 555-561, 2015.
27. R. M. Lang, M. Bierig, R. B. Devereux et al., "Recommendations for chamber quantification, " European Journal of Echocardiography, vol. 7, no. 2, pp. 79-108, 2006.
28. O. Duicu, C. Jusca, L. Falnita et al., "Substrate-specific impairment ofmitochondrial respiration in permeabilized fibers from patients with coronary heart disease versus valvular disease, " Molecular and Cellular Biochemistry, vol. 379, no. 1-2, pp. 229-234, 2013.
29. M. A. Birch-Machin and D. M. Turnbull, "Assaying mitochondrial respiratory complex activity inmitochondria isolated from human cells and tissues, " Methods in Cell Biology, vol. 65, pp. 97-117, 2001.
30. J. D. Miller, Y. Chu, R. M. Brooks, W. E. Richenbacher, R. Peña-Silva, and D. D. Heistad, "Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans, " Journal of the American College of Cardiology, vol. 52, no. 10, pp. 843-850, 2008.
31. F. de Chaumont, S. Dallongeville, N. Chenouard et al., "Icy: an open bioimage informatics platform for extended reproducible research, " Nature Methods, vol. 9, no. 7, pp. 690-696, 2012.
32. A. Alexa, F. Baderca, R. Lighezan, D. E. Žahoi, and D. Izvernariu, "The diagnostic value of EMA expression in the renal parenchyma tumors, " Romanian Journal of Morphology and Embryology, vol. 52, no. 3, pp. 1019-1025, 2012.
33. N. Stride, S. Larsen, M. Hey-Mogensen et al., "Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction, " European Journal of Heart Failure, vol. 15, no. 2, pp. 150-157, 2013.
34. H. Lemieux and C. L. Hoppel, "Mitochondria in the human heart, " Journal of Bioenergetics and Biomembranes, vol. 41, no. 2, pp. 99-106, 2009.
35. N. S. Dhalla, N. Takeda, D. Rodriguez-Leyva, and V. Elimban, "Mechanisms of subcellular remodeling in heart failure due to diabetes, " Heart Failure Reviews, vol. 19, no. 1, pp. 87-99, 2014.
36. V. G. Sharov, A. V. Todor, N. Silverman, S. Goldstein, and H. N. Sabbah, "Abnormal mitochondrial respiration in failed human myocardium, " Journal ofMolecular and Cellular Cardiology, vol. 32, no. 12, pp. 2361-2367, 2000.
37. S. D. Martin and S. L. McGee, "The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes, " Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1840, no. 4, pp. 1303-1312, 2014.
38. E. J. Anderson, J. T. Efird, S. W. Davies et al., "Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation, "The Journal of the American Heart Association, vol. 3, no. 1, Article ID e000713, 2014.
39. G. Nickenig, "Should angiotensin II receptor blockers and statins be combined?" Circulation, vol. 110, no. 8, pp. 1013-1020, 2004.
40. C. C. Wang, E. Billett, A. Borchert, H. Kuhn, and C. Ufer, "Monoamine oxidases in development, " Cellular and Molecular Life Sciences, vol. 70, no. 4, pp. 599-630, 2013.
41. N. Kaludercic, A. Carpi, T. Nagayama et al., "Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts, " Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 267-280, 2014.
42. O.-J. How, E. Aasum, D. L. Severson, W. Y. A. Chan, M. F. Essop, and T. S. Larsen, "Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice, " Diabetes, vol. 55, no. 2, pp. 466-473, 2006.
43. V. T. Dao, A. I. Casas, G. J. Maghzal et al., "Pharmacology and clinical drug candidates in Redox medicine, " Antioxidants & Redox Signaling, vol. 23, no. 14, pp. 1113-1129, 2015.
44. N. Kaludercic, S. Deshwal, and F. Di Lisa, "Reactive oxygen species and redox compartmentalization, " Frontiers in Physiology, vol. 5, Article ID00285, 2014.
45. R. P. Brandes, "Vascular functions of NADPH oxidases, " Hypertension, vol. 56, no. 1, pp. 17-21, 2010.
46. Y. Ohara, T. E. Peterson, H. S. Sayegh, R. R. Subramanian, J. N. Wilcox, and D. G. Harrison, "Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production, " Circulation, vol. 92, no. 4, pp. 898-903, 1995.
47. H.-P. Volz and C. H. Gleiter, "Monoamine oxidase inhibitors. A perspective on their use in the elderly, " Drugs and Aging, vol. 13, no. 5, pp. 341-355, 1998.
48. A. Sturza, L. Noveanu, O. Duicu, M. Danila, N. Jost, and D. Muntean, "Reversible monoamine oxidase-a inhibition improves vascular dysfunction in canine carotid arteries exposed to angiotensin II, " Revista de Chimie, vol. 66, no. 6, pp. 851-854, 2015.